Skip to main content
PEN logo

PEN

Penumbra, Inc.

$318.11

0.05%

Trade Ideas Performance

Latest Closed Trade Idea

$318.11

0.05%
Loading...
We are loading your data. Please wait a moment.

Sentiment

News

31

Social

29

About

Events of Penumbra, Inc. (PEN)

Penumbra's stock has been impacted by Boston Scientific's acquisition announcement, earnings reports, stock performance, analyst rating changes, and insider selling. Boston Scientific announced its intent to acquire Penumbra in January 2026, which was approved by Penumbra shareholders in May 2026. Penumbra reported mixed Q1 2026 earnings, surpassing revenue expectations but missing EPS estimates. Analyst ratings have been adjusted by various firms, and insiders have sold shares of the company's stock.

FAQ

Related Assets

Price action provided by Massive. Fundamentals, news and corporate events provided by FactSet. NLP support provided by Perplexity & Gemini. All data is provided for informational purposes only.

Make every trade make sense.

Sign up free. No card required. Three trade ideas a day, the AI analyst, the community - on us.

Get started for FREE (opens in new tab)
Edge Hound mobile app preview on iPhone

Join us and trade with people
who think like you.

The Edge Hound Discord is where serious self-directed investors talk strategy, share setups, and learn from each other. Free to join with any plan - including Free.

Free to join with any plan - including Free.

Join our Discord community (opens in new tab)
Penumbra, Inc. (PEN) Live Stock Price, Chart & Financial News | Edge Hound